Hilmi Kaan Kaya
Papers
1
Total Citations
16
H-Index
1
About
Hilmi Kaan Kaya is a rising researcher at the forefront of smart drug delivery systems and nanorobotics. His work focuses on the design and synthesis of catalytic micro- and nanomotors, particularly those functionalized with phenylboronic acid for targeted cancer therapy. Kaya’s most cited paper, "Paclitaxel-conjugated phenylboronic acid-enriched catalytic robots as smart drug delivery systems" (2022, 16 citations), introduces a novel approach where chemotherapeutic agents are directly conjugated to self-propelled catalytic robots. This innovation enables precise, on-demand drug release at tumor sites, significantly enhancing therapeutic efficacy while minimizing systemic toxicity. By integrating enzyme-like catalytic activity with stimuli-responsive polymers, Kaya’s robots can navigate complex biological environments, offering a promising platform for personalized medicine. His contributions have already garnered attention for bridging materials science and oncology, with potential applications in targeted chemotherapy and theranostics. As an early-career scientist, Kaya’s work exemplifies the next generation of intelligent, autonomous drug carriers, setting the stage for transformative advances in nanomedicine.
Research Focus
Key Achievements
Top Papers
- 1